https://beelinemedicines.com/presentations-publications/ 2026-10-28T14:53:34+00:00 https://beelinemedicines.com/presentations-publications/afimetoran-a-potent-and-selective-inhibitor-of-human-toll-like-receptor-7-tlr-7-and-tlr-8-provides-robust-efficacy-in-a-murine-lupus-model-of-advanced-disease/ 2026-10-07T16:28:48+00:00 https://beelinemedicines.com/presentations-publications/a-phase-2b-study-of-afimetoran-bms-986256-in-patients-with-active-systemic-lupus-erythematosus-optimization-of-a-lupus-clinical-trial-design/ 2026-10-07T16:28:48+00:00 https://beelinemedicines.com/presentations-publications/bms-986256-an-oral-novel-toll-like-receptor-7-and-8-tlr7-8-inhibitor-does-not-affect-the-pharmacokinetics-of-mycophenolate-mofetil-in-healthy-subjects/ 2026-10-07T16:28:49+00:00 https://beelinemedicines.com/presentations-publications/dimeric-antagonists-of-endosomal-toll-like-receptors-7-8-and-9-tlr7-8-9/ 2026-10-07T16:28:49+00:00 https://beelinemedicines.com/presentations-publications/bms-986256-an-oral-novel-toll-like-receptor-7-and-8-tlr7-8-inhibitor-is-not-a-sensitive-substrate-of-cytochrome-p450-3a4-clinical-evaluation-with-itraconazole/ 2026-10-07T16:28:49+00:00 https://beelinemedicines.com/presentations-publications/first-in-human-safety-pharmacokinetic-and-pharmacodynamic-study-of-escalating-single-and-multiple-doses-of-bms-986256-a-novel-potent-oral-inhibitor-of-tlr7-and-tlr8/ 2026-10-07T16:28:50+00:00 https://beelinemedicines.com/presentations-publications/identification-of-trisubstituted-pyrazoles-as-potent-and-selective-dual-antagonists-of-toll-like-receptors-7-and-8-tlr-7-8-for-the-treatment-of-lupus/ 2026-10-07T16:28:50+00:00 https://beelinemedicines.com/presentations-publications/identification-of-2-pyridinyl-indoles-as-selective-dual-antagonists-of-the-toll-like-receptors-7-and-8-tlr7-8-for-the-treatment-of-autoimmune-diseases/ 2026-10-07T16:28:50+00:00 https://beelinemedicines.com/presentations-publications/discovery-of-bms-986256-a-small-molecule-dual-antagonist-of-the-toll-like-receptors-7-and-8-tlr7-8-advanced-to-clinical-trials-for-the-treatment-of-lupus/ 2026-10-07T16:28:50+00:00 https://beelinemedicines.com/presentations-publications/in-vitro-evidence-demonstrates-that-afimetoran-bms-986256-an-equipotent-tlr7-8-dual-antagonist-has-steroid-sparing-potential-in-the-clinic/ 2026-10-07T16:28:51+00:00 https://beelinemedicines.com/presentations-publications/pharmacodynamic-effects-and-exploratory-efficacy-of-afimetoran-a-tlr7-8-inhibitor-in-patients-with-cutaneous-lupus-erythematosus/ 2026-10-07T16:28:52+00:00 https://beelinemedicines.com/presentations-publications/safety-tolerability-efficacy-pharmacokinetics-and-pharmacodynamics-of-afimetoran-a-toll-like-receptor-7-and-8-inhibitor-in-patients-with-cutaneous-lupus-erythematosus-a-phase-1b-randomized-dou/ 2026-10-07T16:28:53+00:00 https://beelinemedicines.com/presentations-publications/steroid-sparing-effects-of-afimetoran-bms-986256-an-equipotent-toll-like-receptor-tlr7-and-tlr8-antagonist-in-a-lupus-mouse-model/ 2026-10-07T16:28:54+00:00 https://beelinemedicines.com/presentations-publications/structure-based-design-of-2-pyridin-21h-oneindoles-as-antagonists-of-the-toll-like-receptorstlr7-and-tlr8-for-the-treatment-of-autoimmune-diseases/ 2026-10-07T16:28:54+00:00 https://beelinemedicines.com/presentations-publications/afimetoran-bms-986256-an-equipotent-tlr7-8-antagonist-demonstrates-steroid-sparing-effects-in-a-lupus-mouse-model/ 2026-10-07T16:31:24+00:00 https://beelinemedicines.com/presentations-publications/tlr7-inhibition-with-bms-986256-a-potent-and-selective-inhibitor-of-human-tlr-7-and-8-provides-robust-efficacy-in-the-mrl-lpr-female-mouse-model-of-cutaneous-lupus/ 2026-10-07T16:33:55+00:00 https://beelinemedicines.com/presentations-publications/optimization-of-antagonists-of-toll-like-receptors-7-and-8-tlr7-8-leading-to-the-discovery-of-afimetoran/ 2026-10-07T16:55:20+00:00 https://beelinemedicines.com/presentations-publications/safety-tolerability-and-exploratory-efficacy-of-afimetoran-a-tlr7-8-inhibitor-in-patients-with-cutaneous-lupus-erythematosus-a-phase-1b-randomized-double-blind-placebo-controlled-study/ 2026-10-07T16:56:08+00:00 https://beelinemedicines.com/presentations-publications/discovery-of-afimetoran-a-small-molecule-dual-antagonist-of-the-toll-like-receptors-7-and-8-tlr7-8-advanced-to-clinical-evaluation-in-patients-with-lupus/ 2026-10-07T16:56:23+00:00 https://beelinemedicines.com/presentations-publications/optimization-of-indole-based-antagonists-of-toll-like-receptors-7-and-8-tlr7-8/ 2026-10-07T16:56:28+00:00 https://beelinemedicines.com/presentations-publications/inhibition-of-toll-like-receptor-7-tlr7-with-the-potent-and-selective-inhibitor-of-human-tlr7-and-tlr8-bms-986256-provides-robust-efficacy-in-murine-lupus-models-reversing-established-disease/ 2026-10-07T16:56:35+00:00 https://beelinemedicines.com/presentations-publications/in-vitro-and-in-vivo-evidence-of-the-steroid-sparing-potential-of-afimetoran-an-equipotent-toll-like-receptor-7-8-dual-antagonist/ 2026-10-07T17:13:54+00:00 https://beelinemedicines.com/presentations-publications/pharmacodynamic-effects-and-exploratory-efficacy-of-afimetoran-a-tlr7-8-inhibitor-in-patients-with-cutaneous-lupus-erythematosus-2/ 2026-10-07T17:15:04+00:00 https://beelinemedicines.com/presentations-publications/exploration-of-carbazole-based-antagonists-of-toll-like-receptors-7-and-8-tlr7-8-generated-via-structure-guided-evolution-of-an-indole-series/ 2026-10-07T17:32:58+00:00 https://beelinemedicines.com/presentations-publications/optimization-of-4h-pyrrolo32-dthiazolebasedantagonists-of-toll-like-receptors-7-and-8-tlr7-8-for-the-treatment-of-lupus/ 2026-10-07T17:34:45+00:00 https://beelinemedicines.com/presentations-publications/tlr7-8-blockade-by-bms-905-a-structural-analog-of-afimetoran-drives-transcriptional-rewiring-of-kidney-inflammation-in-a-mouse-model-of-sle/ 2026-10-26T17:22:43+00:00 https://beelinemedicines.com/presentations-publications/afimetoran-an-oral-equipotent-dual-antagonist-of-toll-like-receptor-7-tlr7-and-tlr8-in-combination-with-an-anti-tnf-results-in-increased-efficacy-in-a-collagen-induced-arthritis-model/ 2026-10-26T17:23:44+00:00 https://beelinemedicines.com/presentations-publications/a-phase-2-multicenter-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-afimetoran-an-oral-once-daily-equipotent-tlr-7-8-inhibitor-in-participants-with-act/ 2026-10-28T14:53:34+00:00